Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging.

Increased risk of hemorrhagic transformation (HT) limits the general use of thrombolytic therapy in acute ischemic stroke (AIS). This study shows that early blood-brain barrier defects in AIS can be assessed by using permeability MR imaging. Significantly increased permeability was found in 3 patients who later hemorrhaged. This method indicates the potential for identifying patients at higher risk of HT and offers the use of physiologic imaging rather than time from onset of symptoms to guide treatment decisions.

[1]  T Moulin,et al.  Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. , 1999, Stroke.

[2]  J. Baron,et al.  Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. , 1995, Stroke.

[3]  T. N. t-P. S. S. Group,et al.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. , 1997, Stroke.

[4]  D. Lawrence,et al.  Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. , 2003, The Journal of clinical investigation.

[5]  Lyden Pd,et al.  Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. , 1993, Cerebrovascular and brain metabolism reviews.

[6]  G. Sette,et al.  Hemorrhagic transformation of brain infarct , 1996, Neurology.

[7]  W P Dillon,et al.  Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. , 2001, Academic radiology.

[8]  G. Hamann,et al.  Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke , 1998, Journal of neurology, neurosurgery, and psychiatry.

[9]  V Larrue,et al.  Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. , 1997, Stroke.

[10]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[11]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[12]  C. Camfield,et al.  Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less , 1996, Neurology.

[13]  K. Muir,et al.  Neuroprotection for acute stroke: making clinical trials work. , 1999, Stroke.

[14]  M. Eliasziw,et al.  Comparison of MRI and CT for detection of acute intracerebral hemorrhage. , 2005, JAMA.

[15]  M. Hommel,et al.  Thrombolytic therapy with streptokinase in acute ischemic stroke. , 1996, The New England journal of medicine.